Product Highlight - Apixaban (Embolis 2.5/Embolis 5)

27 Feb 2024
Product Highlight - Apixaban (Embolis 2.5/Embolis 5)

      Power to conquer NVAF

  •  Indicated for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors.1
  •  1st branded generic manufactured in a USFDA audited plant.2
  •  Available at Mercury Drug, Watsons, Rose Pharmacy, Southstar Drug and other leading drugstores in the Philippines.

REFERENCES:
1. Full Prescribing Information of Apixaban (Embolis 2.5/Embolis 5) – 17 August 2022
2. PH FDA CGMP Compliance|Cadila Healthcare Ltd Moraiya 2022


Zydus Healthcare Philippines, Inc.
Unit 903-904, 9th Floor, Eco Tower,
32nd Street corner 9th Avenue,
Bonifacio Global City, Taguig City 1634
Tel No: (+63-2) 8815 1124

Related MIMS Drugs